Why Chrissy Metz Finally Said Yes to a GLP-1 After Being a "Skeptic" for Years

Chrissy Metz, known for her role in the series 'This Is Us,' has publicly disclosed that she is now using a GLP-1 medication to aid in weight loss. This announcement comes alongside the debut of new photographs showcasing a major weight loss transformation for the actress. Metz noted that this decision followed a long period of hesitation, describing her previous mindset toward weight-loss drugs as being very skeptical. The transition from skeptic to user marks a significant shift in her personal health journey, which she has now shared with the public. Coverage of this revelation has been widespread across several entertainment and news outlets. Entertainment Weekly, NewsNation, and E!

News all highlighted Metz's admission that she had been a skeptic regarding these specific medications for years before deciding to utilize them. Additionally, reports from usatoday.com focused on the shift in her mindset, while Yahoo centered its coverage on the visual evidence of her transformation through the release of new photos. These outlets collectively emphasize the contradiction between her long-term doubts and her current medical choice. The context of this trend involves the rising prominence of GLP-1 medications in the public eye and their increasing use by high-profile figures. For Metz, the shift is particularly noteworthy because of her previous public stance of skepticism. This context illustrates a broader trend of public figures documenting their experiences with medical weight loss interventions.

The coverage suggests that her decision was not immediate, but rather the result of a process that overcame years of uncertainty regarding the efficacy or appropriateness of such drugs. Looking forward, the coverage indicates that the public will be watching the ongoing results of Metz's weight loss transformation as seen in her recent photographs. While the reports do not specify further medical plans, they establish the fact that Metz has moved past her skeptical phase to adopt the GLP-1 treatment. Observers will likely track whether the actress provides more detailed insights into what specifically prompted her to change her mind after years of doubt, as the current reports primarily focus on the fact of the change itself.